---
$id: https://graph.org.ai/products/commodity/51161558
$type: Product
source: UNSPSC
code: "51161558"
title: "Nivimedone"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Nivimedone

**UNSPSC Code**: 51161558
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a mast cell stabilizer with the molecular formula C11H9NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 1M887244YI chemically known as 1h-indene-1,3(2h)-dione, 5,6-dimethyl-2-nitro-, ion(1-) but generally known as nivimedone, which bears US NIH Compound Identifier 64753. European Medicines Agency schedules Nivimedone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09333MIG. The term NIVIMEDONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, no10, 1977, list 17). Most nations schedule nivimedone under HS 29147000 and SITC 51629. As of Q4 2014, NIVIMEDONE remains the US FDA Preferred Term for this commodity. Nivimedone bears US NLM identifiers UMLS ID C0068885 and NCI Concept Code C84021. SMILES: CC1=C(C=C2C(=C1)C(=O)C(C2=O)[N+](=O)[O-])C.

